LMR Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

LMR Partners’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,878	Closed	-$7.56M	–	1367
2023 Q4	$7.56M	Buy	23,878 +20,302	+568%	+$3.95M	0.09%	231
2023 Q3	$605K	Hold	3,576	–	–	0.01%	542
2023 Q2	$775K	Buy	+3,576	New	+$766K	0.01%	450
2021 Q2	–	Sell	-20,000	Closed	-$2.4M	–	1383
2021 Q1	$2.4M	Buy	+20,000	New	+$2.27M	0.06%	301

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

LMR Partners's KRTX Position: Q1 2024 in Review

LMR Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 23,878 shares — an estimated $7.56M sold.

LMR Partners first reported a position in KRTX in Q1 2021 and held it in 4 quarters. The position peaked at $7.56M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

LMR Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 23,878 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.56M.
LMR Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
LMR Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $7.56M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.